Autism spectrum disorders (ASDs) have long been noted to affect many more males than females, and accordingly, sex-specific factors have been hypothesized to increase males' risk for, or protect females from, ASDs. However, no such factor has been definitively implicated in ASD etiology that can account for its male-biased prevalence, nor is it known whether the major drivers of sex-differential liability act as male-specific risk factors or as female-specific protective factors. Bringing fresh evidence to this question, Robinson et al.
Autism spectrum disorders (ASDs) have long been noted to affect many more males than females, and accordingly, sex-specific factors have been hypothesized to increase males' risk for, or protect females from, ASDs. However, no such factor has been definitively implicated in ASD etiology that can account for its male-biased prevalence, nor is it known whether the major drivers of sex-differential liability act as male-specific risk factors or as female-specific protective factors. Bringing fresh evidence to this question, Robinson et al. (1) report in PNAS the strongest support to date for a female protective effect (FPE) against autistic behavior, as measured quantitatively in general population samples.
The premise of the FPE model is simple: if a female-specific factor protects females across the board from reaching the threshold for ASD diagnosis, then those females who are affected are likely carrying a greater etiological load (e.g., genetic variants or environmental influences) than affected males who lack this female-specific protective factor. Because ASDs are highly heritable (2), supporting a role for familial genetic variation in ASD etiology, this model further predicts that relatives of autistic females should be at increased risk for ASD when compared with relatives of autistic males, who carry less genetic liability on average. A complementary model is that of male-specific risk for ASDs, in which a male-specific factor, such as testosterone, increases males' vulnerability to etiological factors relative to females (3, 4) . Both models can account for a male predominance among ASD cases, and are not necessarily exclusive. Recent studies of de novo variation in ASD cases appear to support the FPE model, finding a greater proportion of female cases with deleterious, large copy number variants and single nucleotide variants, compared with males (5) (6) (7) (8) (9) (10) (11) . One of these studies also noted an increased frequency of copy number variants in unaffected female siblings of autistic cases, lending further support to the theory that females are able to withstand greater genetic liability than males without becoming affected (7) .
In contrast to this evidence from de novo genetic risk, studies addressing heritable risk for ASD in families ascertained for research have been less supportive of the FPE model. For example, a study of over 800 families with an autistic child did not find an increased rate of ASD among first-and second-degree relatives of female ASD probands compared with males (12) . Additionally, two prospective surveillance studies of the high-risk infant siblings of earlier-born ASD probands find a statistically significant effect of sibling, but not proband, sex on ASD risk on the recurrence rate for ASDs (13, 14) . Findings from a recent, large, twin study are similar, with only the sex of the cotwin significantly affecting recurrence rate (2) . However, each of these studies evaluated categorical diagnostic status within clinically ascertained populations, and as Robinson et al. (1) aptly emphasize, underlying differences in ascertainment by proband sex may significantly confound the interpretation of such studies. Supportive of this theory, evaluation of quantitative autistic traits in family members did find significant, but moderate, effects of both sibling and proband sex on social responsiveness scale score (15) , suggesting that quantitative measurements may be more sensitive to increased etiological loading in relatives of autistic females than recurrence risk for categorical, clinical diagnoses.
A Quantitative, Population-based Approach
To avoid the confounders of ascertainment and categorical diagnosis, Robinson et al. (1) apply a quantitative trait approach to two large, general population samples, using the Childhood Autism Spectrum Test and the Autism-Tics, Attention Deficit Hyperactivity Disorder, and other Comorbidities inventory to assay autistic traits in over 9000 total dizygotic twin pairs from the Twins Early Development Study, and the Child and Adolescent Twin Study of Sweden, respectively. Instead of identifying affected cases by clinical evaluation or parent-reported diagnostic status, the authors define as probands those subjects scoring above the 90th percentile for the cohort on either instrument. Robinson et al. (1) then compare recurrence risk for scores surpassing the 90th percentile in siblings of male versus female probands, as well as evaluate the shift in normalized autistic behavior scores from the sample mean for siblings of male and female probands. This approach is based on the assumption that the distribution of etiological contributors to ASD is not modal, with different etiologies driving mild presentations and the most severe manifestations of autistic traits, but is instead continuous, with the same etiological contributors driving subthreshold and severe presentations of autistic behavior. Observations of subthreshold autistic-like traits, often referred to as the broader autism phenotype, in family members of autistic cases are consistent with this model (16) , and previous work from Robinson et al. (17) in the Twins Early Development Study cohort has demonstrated a continuous shift toward higher autistic behavior scores in cotwins of probands across a range of severity, from those scoring above the 90th, 95th, and 99th percentiles.
Robinson et al. (1) find that the mean, normalized scores from siblings of quantitatively defined female probands are significantly higher than the sample mean, and higher than the scores from siblings of male probands. The authors also find recurrence risk for autistic behavior scores above the 90th percentile to be significantly greater for siblings of female than male probands. This difference was observed whether a sexspecific or sex-averaged distribution was used. The increased recurrence risk in siblings of female probands is consistent with a key prediction of the FPE model: that affected females and their relatives share an increased etiological load compared with affected males and their relatives. This general population sample is the largest to be evaluated for autistic behavior to date, providing sufficient power to observe statistically significant shifts in siblings' scores within one SD of the sample mean. Additionally, the study of an unbiased, general population sample that was not recruited for preexisting ASD diagnoses, and the application of an objective, quantitative threshold to assign categorical proband status, likely avoided ill effects of ascertainment biases resulting from factors such as sex, access to health care, intellectual functioning, and comorbidities on the outcome of the analysis. The instruments used are short questionnaires based on parent report, which could be considered a minor weakness. However, this minor aspect is counterbalanced by the large cohort evaluated and the virtually identical results in two distinct samples from different countries, using different instruments.
Implications for Future Research
The findings from Robinson et al. (1) support two main theories pertaining to the architecture of ASD etiology. The first theory is the contribution from a FPE, in that first degree relatives of affected females in this study are found to carry a greater etiological load than those of affected males, as evidenced by higher autistic behavior scores and recurrence risk in female probands' siblings. This greater familial load in females scoring above the 90th percentile of the sample-wide, non-sex-specific distribution demonstrates that females are protected from a wider range of liability than males, and that greater total liability is required to override the actions of a female-protective factor and effect diagnostic levels of autistic behavior. Because it is unclear how much of the 4:1 male-to-female bias in ASD prevalence these data could explain, this framework does not preclude contributions from male-specific risk factors that increase males' vulnerability to lesser etiological loading. Male risk and female protective factors are not mutually exclusive and both may underlie the sex bias in ASD.
However, the data presented by Robinson et al. (1) make a strong case that studies aiming to elucidate the sex-differential mechanisms responsible for male-biased ASD prevalence may do well to focus on femalespecific biology, which has not been a major focus up to this point. Furthermore, evidence for a FPE against the broad distribution of autistic behavior is promising for the development of ASD therapeutics, an endeavor that has become increasingly daunting given recent estimations that hundreds of genes are likely to be implicated in ASD risk (7, 8 are continuously distributed and not modal, demonstrating that the same, shared etiological factors influence diagnostic-level and subthreshold autistic behavior within families. This finding has been suggested by evidence of autistic-like traits in family members of autistic cases, and additive effects of common genetic variants have been implicated as a significant contributor, explaining as much as 60% of liability for ASD in multiplex families (more than one autistic member) (18) .
In addition, rare copy number and single nucleotide variants of predicted large effect show variable penetrance, consistent with a modulating effect of genetic background (including common and other rare variations) or environmental influences on the pathogenicity of these variants. As the field continues to identify de novo risk variants for ASD, findings from this work serve as a reminder that even the penetrance of rare variants with predicted deleterious outcomes is likely influenced in no insignificant way by more continuously distributed etiological factors.
Looking forward, the findings of Robinson et al. (1) may inform the design and interpretation of genetic studies of ASD. Specifically, evidence of association of common etiological factors with pathogenic and subthreshold presentations of autistic behaviors make a strong case for the value of using quantitative trait measurements from individuals and family members with and without ASD diagnoses in association testing and linkage analyses for ASDs. Furthermore, genetic tests that focus on subsets of families with quantitative trait measures above a sample-normalized mean may help to enrich for families with a greater contribution from inherited, as opposed to purely de novo, genetic risk factors. Furthermore, given the support for an increased etiological load in high-scoring females, genetic studies of families with affected females or casecontrol analyses of female samples may facilitate identification of variants of relatively high penetrance compared with those found in male-focused samples. This success in the study of general population cohorts with quantitative traits provides a framework for designing successful future genetic and etiological studies of ASDs, and as the mechanism responsible for the sex-biased prevalence of ASDs is still poorly understood, the findings reported by Robinson et al. (1) indicate that a search for female-specific protective factors is warranted.
